Cargando…

Relationships of Cuproptosis-Related Genes With Clinical Outcomes and the Tumour Immune Microenvironment in Hepatocellular Carcinoma

Background: Cuproptosis is a recently identified form of regulated cell death that plays a critical role in the onset and progression of various cancers. However, the effects of cuproptosis-related genes (CRGs) on hepatocellular carcinoma (HCC) are poorly understood. This study aimed to identify the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xi, Hu, Gang, Xiong, Li, Xu, Qingqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pathology and Oncology Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532508/ https://www.ncbi.nlm.nih.gov/pubmed/36213162 http://dx.doi.org/10.3389/pore.2022.1610558

Ejemplares similares

Holliday Cross-Recognition Protein HJURP: Association With the Tumor Microenvironment in Hepatocellular Carcinoma and With Patient Prognosis
por: Luo, Dongcheng, et al.
Publicado: (2022)

Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma
por: Ying, Leqian, et al.
Publicado: (2021)

The Role of Tumor Microenvironment and Immune Response in Colorectal Cancer Development and Prognosis
por: Wozniakova, Maria, et al.
Publicado: (2022)

NAD+ biosynthesis metabolism predicts prognosis and indicates immune microenvironment for breast cancer
por: Yang, Yuting, et al.
Publicado: (2023)

The Diagnostic Significance of CXCL13 in M2 Tumor Immune Microenvironment of Human Astrocytoma
por: Chang, Shu-Jyuan, et al.
Publicado: (2022)

Identification and Characterization of Genes Related to the Prognosis of Hepatocellular Carcinoma Based on Single-Cell Sequencing
por: Chen, Wenbiao, et al.
Publicado: (2022)

Clinicopathological Implications of ASAP1 Expression in Hepatocellular Carcinoma
por: Bang, Seongsik, et al.
Publicado: (2022)

KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker
por: Shen, Xiaoju, et al.
Publicado: (2022)

Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma
por: Zhong, Zixuan, et al.
Publicado: (2022)

Immunohistochemical Expressions of Senescence-Associated Secretory Phenotype and Its Association With Immune Microenvironments and Clinicopathological Factors in Invasive Breast Cancer
por: Park, Min Hui, et al.
Publicado: (2021)

Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma
por: Ma, Wanshan, et al.
Publicado: (2022)

A Risk Model Based on Immune-Related Genes Predicts Prognosis and Characterizes the Immune Landscape in Esophageal Cancer
por: Xie, Yan, et al.
Publicado: (2022)

The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis
por: Zhao, Xueying, et al.
Publicado: (2022)

Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma
por: Jiang, Xili, et al.
Publicado: (2021)

Construction of a Metabolism-Related Long Non-Coding RNAs-Based Risk Score Model of Hepatocellular Carcinoma for Prognosis and Personalized Treatment Prediction
por: Zhang, Peichen, et al.
Publicado: (2022)

Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report
por: Han, Wen, et al.
Publicado: (2023)

Using Patient-Derived Xenografts to Explore the Efficacy of Treating Head-and-Neck Squamous Cell Carcinoma With Anlotinib
por: Hu, Fangling, et al.
Publicado: (2021)

An Immunohistochemical Study of β-catenin Expression and Immune Cell Population in Metastatic Carcinoma to the Liver
por: Au, Kwan-Yung, et al.
Publicado: (2021)

An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer via affecting immune cell infiltration landscape
por: Xiong, Siping, et al.
Publicado: (2022)

Prognostic value of long non-coding RNA MALAT1 in hepatocellular carcinoma: A study based on multi-omics analysis and RT-PCR validation
por: Liao, Xiaoli, et al.
Publicado: (2023)

Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic target
por: Greimelmaier, K., et al.
Publicado: (2023)

APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis
por: Cao, Xiying, et al.
Publicado: (2023)

Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status
por: Refaat, Bassem, et al.
Publicado: (2021)

The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2022)

SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma
por: Yang, Meng-Ling, et al.
Publicado: (2021)

Fucosyltransferase 8 is Overexpressed and Influences Clinical Outcomes in Lung Adenocarcinoma Patients
por: Liang, Yiqian, et al.
Publicado: (2022)

Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations
por: Chen, Tongbing, et al.
Publicado: (2023)

Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma
por: Gyulai, Marton, et al.
Publicado: (2023)

Analysis of cuproptosis in hepatocellular carcinoma using multi-omics reveals a comprehensive HCC landscape and the immune patterns of cuproptosis
por: Li, Xinqiang, et al.
Publicado: (2022)

Predicting prognosis and clinical efficacy of immune checkpoint blockade therapy via interferon-alpha response in muscle-invasive bladder cancer
por: Fan, Bohan, et al.
Publicado: (2023)

Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel
por: Kobayashi, Yusuke, et al.
Publicado: (2021)

Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods
por: Liang, Zi-Qian, et al.
Publicado: (2022)

Use of Diagnostic Imaging Modalities in Modern Screening, Diagnostics and Management of Breast Tumours 1st Central-Eastern European Professional Consensus Statement on Breast Cancer
por: Forrai, Gábor, et al.
Publicado: (2022)

Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2022)

Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2023)

An epithelial–mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods
por: Gao, Li, et al.
Publicado: (2022)

Single-cell transcriptome analysis reveals the clinical implications of myeloid-derived suppressor cells in head and neck squamous cell carcinoma
por: Jiang, Wenru, et al.
Publicado: (2023)

The Diagnostic Value of Pan-Trk Expression to Detect Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion in CNS Tumours: A Study Using Next-Generation Sequencing Platform
por: Mohamed, Fawaz, et al.
Publicado: (2022)

Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma
por: Dong, Yinlei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e0a2du4cqelploa1vlfcojdj7f